JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.51B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$818M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$596M |
| 4 |
Eaton
ETN
|
+$577M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$557M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$727M |
| 3 |
Starbucks
SBUX
|
+$679M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$565M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$458M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.34% |
| 2 | Technology | 11.83% |
| 3 | Healthcare | 9.48% |
| 4 | Consumer Discretionary | 7.99% |
| 5 | Industrials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
PUT
VeriSign
VRSN
$26.7B
| $18.7M | ﹤0.01% |
176,600
+11,100
| +7% | +$1.12M |
|
|
PIR
1502
DELISTED
Pier 1 Imports, Inc.
PIR
| $18.6M | ﹤0.01% |
221,920
-7,436
| -3% | -$665K |
|
1503
Brink's
BCO
$4.55B
| $18.6M | ﹤0.01% |
224,285
+112,757
| +101% | +$8.59M |
|
|
FOLD
1504
DELISTED
Amicus Therapeutics
FOLD
| $18.6M | ﹤0.01% |
1,262,000
-19,633
| -2% | -$260K |
|
|
AVTA
1505
DELISTED
Avantax, Inc. Common Stock
AVTA
| $18.5M | ﹤0.01% |
726,650
+209,175
| +40% | +$4.74M |
|
1506
Rayonier Advanced Materials
RYAM
$592M
| $18.4M | ﹤0.01% |
1,344,632
-118,312
| -8% | -$1.69M |
|
|
VVC
1507
DELISTED
Vectren Corporation
VVC
| $18.4M | ﹤0.01% |
278,753
-27,671
| -9% | -$1.73M |
|
1508
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$43.9B
| $18.4M | ﹤0.01% |
226,400
+86,100
| +61% | +$6.91M |
|
1509
CAE Inc. Common Shares
CAE
$8.65B
| $18.4M | ﹤0.01% |
1,058,580
-58,525
| -5% | -$987K |
|
1510
Nuveen Floating Rate Income Fund
JFR
$1.25B
| $18.3M | ﹤0.01% |
1,566,000
| – | – |
|
|
CCC
1511
DELISTED
Calgon Carbon Corp
CCC
| $18.3M | ﹤0.01% |
853,931
+774,981
| +982% | +$11.7M |
|
1512
Preferred Bank
PFBC
$1.24B
| $18.2M | ﹤0.01% |
302,729
-1,110
| -0.4% | -$61.2K |
|
1513
Transocean
RIG
$6.32B
| $18.2M | ﹤0.01% |
1,721,061
+1,625,641
| +1,704% | +$14M |
|
1514
World Kinect Corp
WKC
$1.91B
| $18.2M | ﹤0.01% |
541,541
+15,030
| +3% | +$536K |
|
|
CIVI
1515
DELISTED
Civitas Resources
CIVI
| $18.2M | ﹤0.01% |
544,116
+103,267
| +23% | +$2.94M |
|
|
BHVN
1516
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $18.2M | ﹤0.01% |
478,253
-114,972
| -19% | -$3.49M |
|
1517
Charles River Laboratories
CRL
$13B
| $18.1M | ﹤0.01% |
169,392
-9,237
| -5% | -$949K |
|
1518
Douglas Emmett
DEI
$1.91B
| $18.1M | ﹤0.01% |
461,729
+133,503
| +41% | +$5.11M |
|
1519
MYR Group
MYRG
$5.17B
| $18.1M | ﹤0.01% |
625,578
-4,258
| -0.7% | -$118K |
|
|
PRFT
1520
DELISTED
Perficient Inc
PRFT
| $18.1M | ﹤0.01% |
930,391
+854,535
| +1,127% | +$15.6M |
|
1521
HSBC
HSBC
$354B
| $18.1M | ﹤0.01% |
401,830
-29,943
| -7% | -$1.32M |
|
1522
Hexcel
HXL
$7.61B
| $18.1M | ﹤0.01% |
315,946
+24,907
| +9% | +$1.34M |
|
|
RDS.A
1523
PUT
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $18M | ﹤0.01% |
298,900
+153,900
| +106% | +$8.61M |
|
|
RATE
1524
DELISTED
Bankrate Inc
RATE
| $18M | ﹤0.01% |
1,293,630
+729,037
| +129% | +$10.1M |
|
|
MDC
1525
DELISTED
M.D.C. Holdings, Inc.
MDC
| $18M | ﹤0.01% |
690,160
+377,793
| +121% | +$9.98M |
|
Similar funds
JP Morgan Chase's Q3 2017 Portfolio in Review
As of Q3 2017, JP Morgan Chase held 5,458 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2017 filing shows 502 new, 2,053 increased, 1,909 reduced and 470 closed positions. Its largest new stake was JBG SMITH: 3,403,127 shares worth $116M. The largest sale was Du Pont De Nemours E I, an estimated $1.4B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q3 2017 buy was JBG SMITH: 3,403,127 shares worth $116M.
- JP Morgan Chase added most to DuPont de Nemours in Q3 2017, an estimated $1.51B increase.
- JP Morgan Chase's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $727M.
- JP Morgan Chase fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.4B.
- JP Morgan Chase's ten largest holdings make up 18% of its $453B portfolio in Q3 2017.
- JP Morgan Chase opened 502 new positions and closed 470 in Q3 2017.
- JP Morgan Chase's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on JP Morgan Chase's 13F filing for Q3 2017, filed 9 Nov 2017.